View Profile

Paola Alberti

Assistant Professor (Human Anatomy) · University of Milano-Bicocca

https://researchid.co/paola.alberti
@unimib.it
104Scopus Publications
6070Google Scholar Citations
42Google Scholar h-index
77Google Scholar i10-index

Biography

Her main expertise is related to peripheral nervous system diseases, especially Chemotherapy-Induced Peripheral Neurotoxicity (CIPN). She is an active member of the Toxic Neuropathy Consortium (TNC), part of the Peripheral Nervous System (PNS) society. During the Residency in Neurology, she was a visiting fellow at Johns Hopkins University (Prof. D.R. Cornblath, MD) to refine her knowledge of neurophysiological techniques. Since 2015 she has been pursuing an interest for preclinical research and joined the Experimental Neurology Unit (ENU, University of Milano-Bicocca) team, where she completed the PhD program in Neuroscience (2019). Her PhD project was focused on Oxaliplatin Induced Peripheral Neurotoxicity in preclinical models: she introduced advanced neurophysiological techniques, nerve excitability testing, to ENU after having learnt them from Prof H. Bostock, (UCL, London). She was a visiting fellow at University of Baltimore (Prof. S.G. Dorsey and Prof C. Renn) where learned DRG

Education

EDUCATION AND TRAINING July 2010: Degree: MD – 110/110 cum laude – University of Milano-Bicocca (Monza, Italy) June 2016 – Degree: Board in Neurology – 70/70 cum laude – University of Milano-Bicocca (Monza, Italy) February 2019 – Degree: PhD in Neuroscience – University of Milano-Bicocca (Monza, Italy)

Recent Scopus Publications

  1. Interleukin-6 as a keystone cytokine in experimental rat models of chemotherapy-induced peripheral neurotoxicity
    Scientific Reports, 2026
  2. Shared and specific molecular mechanisms of proteasome inhibitors in chemotherapy-induced peripheral neurotoxicity
    British Journal of Pharmacology, 2026
  3. Serum neurofilament light chain (sNFL) as a predictive biomarker for Chemotherapy-induced peripheral neurotoxicity (CIPN): consideration of current evidence, validation steps, and barriers to CIPN biomarker implementation in clinical practice—a narrative review
    Supportive Care in Cancer, 2026
  4. Peripheral Nerve Society Training Grant Program: An Exciting Opportunity Not to Be Missed
    Journal of the Peripheral Nervous System, 2025
  5. Molecular Characterization of Oxaliplatin-Induced Peripheral Neurotoxicity: The Complex Spectrum of Painful Manifestations
    Journal of the Peripheral Nervous System, 2025

Links